Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Bioanalytical Systems, Inc.    BASI

BIOANALYTICAL SYSTEMS, INC.

(BASI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: September 2020 2021 2022
Capitalization1 52,5163-
Entreprise Value (EV)1 52,5163163
P/E ratio -11,1x-69,7x163x
Yield ---
Capitalization / Revenue 0,87x2,34x2,12x
EV / Revenue 0,87x2,34x2,12x
EV / EBITDA -37,9x19,7x
Price to Book ---
Nbr of stocks (in thousands) 10 98911 131-
Reference price (USD) 4,7814,614,6
Last update 12/21/2020--
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: September 2020 2021 2022
Net sales1 60,569,776,9
EBITDA1 -4,308,25
Operating profit (EBIT)1 --0,962,39
Operating Margin --1,37%3,11%
Pre-Tax Profit (EBT)1 --2,351,00
Net income1 --2,381,00
Net margin --3,41%1,30%
EPS2 -0,43-0,210,09
Dividend per Share ---
Last update 12/21/2020--
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: September 2020 2021 2022
Net Debt ---
Net Cash position ---
Leverage (Debt / EBITDA) ---
Free Cash Flow ---
ROE (Net Profit / Equities) ---
Shareholders' equity1 ---
ROA (Net Profit / Asset) ---
Assets1 ---
Book Value Per Share ---
Cash Flow per Share ---
Capex1 -2,002,00
Capex / Sales -2,87%2,60%
Last update 12/21/202002/11/202102/11/2021
1 USD in Million
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
162 961 587
Net sales (USD)
60 469 000
Number of employees
409
Sales / Employee (USD)
147 846
Free-Float
54,2%
Free-Float capitalization (USD)
88 398 346
Avg. Exchange 20 sessions (USD)
1 715 064
Average Daily Capital Traded
1,05%
EPS & Dividend